Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value

2.0 / 5 stars · 28/71 Roast Me

PALATIN TECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value

PALATIN TECHNOLOGIES, INC. (PTN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $0 as of 2023-06-30, per its 10-K filed 2023-09-28.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2023-09-28

  • 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
  • 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
  • 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
  • 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $236.36K.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic ValueShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value as first filed
2023-06-30$0.00
10-K · filed 2023-09-28
2023-03-31$0.00
10-Q · filed 2023-05-15
2022-12-31$0.00
10-Q · filed 2023-02-14
2022-03-31$236.36K
10-Q · filed 2022-05-16
2021-12-31$370.83K
10-Q · filed 2022-02-14
2021-09-30$186.89K
10-Q · filed 2021-11-15
2021-06-30$0.00
10-K · filed 2022-09-22
$733.74K
10-K · filed 2021-09-28
2021-03-31$873.61K
10-Q · filed 2021-05-14
2020-12-31$823.99K
10-Q · filed 2021-02-16
2020-09-30$211.60K
10-Q · filed 2020-11-16
2020-06-30$299.14K
10-K · filed 2020-09-25
2020-03-31$84.31K
10-Q · filed 2020-05-11
2019-12-31$990.47K
10-Q · filed 2020-02-10
2019-09-30$1.63M
10-Q · filed 2019-11-12
2019-06-30$3.31M
10-K · filed 2019-09-12
2019-03-31$1.56M
10-Q · filed 2019-05-09
2018-12-31$544.28K
10-Q · filed 2019-02-11
2018-09-30$1.66M
10-Q · filed 2018-11-09
2018-06-30$1.46M
10-K · filed 2018-09-13
2017-06-30$0.00
10-K · filed 2017-09-25
2016-06-30$0.00
10-K · filed 2016-09-19
2015-06-30$285.39K
10-K · filed 2015-09-18
2014-06-30$373.71K
10-K · filed 2014-09-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B